James Shin
Stock Analyst at Deutsche Bank
(2.32)
# 2,573
Out of 4,944 analysts
22
Total ratings
50%
Success rate
1.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintains: Buy | $1,010 → $900 | $660.49 | +36.26% | 5 | Aug 11, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $6.15 | +62.60% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $120.14 | -0.12% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $82.71 | +26.95% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $289.33 | +5.42% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $85.85 | -30.11% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $47.85 | -5.96% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $36.95 | +62.38% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $201.47 | -25.55% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $561.55 | +42.46% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.84 | +443.48% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.77 | +1,454.40% | 1 | Nov 9, 2023 |
Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010 → $900
Current: $660.49
Upside: +36.26%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $6.15
Upside: +62.60%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $120.14
Upside: -0.12%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $82.71
Upside: +26.95%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $289.33
Upside: +5.42%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $85.85
Upside: -30.11%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $47.85
Upside: -5.96%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $36.95
Upside: +62.38%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $201.47
Upside: -25.55%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $561.55
Upside: +42.46%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.84
Upside: +443.48%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $0.77
Upside: +1,454.40%